Premium
PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL)
Author(s) -
Fowler N. H.,
Dickinson M.,
MartinezLopez J.,
Kolstad A.,
Schuster S. J.,
Dreyling M.,
Ghosh M.,
Harigae H.,
Kersten M. José,
Bachy E.,
Popplewell L.,
Chavez J. C.,
Ho P. J.,
Butler J.,
Kato K.,
Tresckow B.,
Ferreri A. J. M.,
Simón J. A. P.,
Patten P. E. M.,
Andreadis C.,
Riedell P. A.,
McGuirk J. P.,
Nastoupil L. J.,
Teshima T.,
Offner F.,
Petzer A.,
Viardot A.,
Zinzani P. L.,
Malladi R.,
Zhang J.,
Tiwari R.,
Bollu V.,
Masood A.,
Thieblemont C.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.178_2880
Subject(s) - refractory (planetary science) , medicine , follicular lymphoma , quality of life (healthcare) , oncology , lymphoma , materials science , metallurgy , nursing